241 related articles for article (PubMed ID: 20838932)
1. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.
Meyer R; Deem S; Yanez ND; Souter M; Lam A; Treggiari MM
Neurocrit Care; 2011 Feb; 14(1):24-36. PubMed ID: 20838932
[TBL] [Abstract][Full Text] [Related]
2. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
3. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice.
Velly LJ; Bilotta F; Fàbregas N; Soehle M; Bruder NJ; Nathanson MH;
Eur J Anaesthesiol; 2015 Mar; 32(3):168-76. PubMed ID: 25303971
[TBL] [Abstract][Full Text] [Related]
4. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.
Tagami T; Kuwamoto K; Watanabe A; Unemoto K; Yokobori S; Matsumoto G; Igarashi Y; Yokota H;
Neurocrit Care; 2014 Dec; 21(3):462-9. PubMed ID: 24865266
[TBL] [Abstract][Full Text] [Related]
5. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
6. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic management of subarachnoid hemorrhage.
Treggiari MM;
Neurocrit Care; 2011 Sep; 15(2):329-35. PubMed ID: 21786046
[TBL] [Abstract][Full Text] [Related]
9. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
Romero Kräuchi O; Verger Bennasar AM
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
[TBL] [Abstract][Full Text] [Related]
10. [Intensive care using hypervolemic hypertensive hemodilution in the acute period of subarachnoidal hemorrhages in patients with arterial aneurysms].
Kurdiumova NV; Parfenov AL; Fokin MS; Grinenko EA; Eliava ShSh; Kheĭreddin AS; Sazonov IA
Zh Vopr Neirokhir Im N N Burdenko; 2006; (2):48-53. PubMed ID: 16827430
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage.
Treggiari MM; Walder B; Suter PM; Romand JA
J Neurosurg; 2003 May; 98(5):978-84. PubMed ID: 12744357
[TBL] [Abstract][Full Text] [Related]
12. Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
Capampangan DJ; Wellik KE; Aguilar MI; Demaerschalk BM; Wingerchuk DM
Neurologist; 2008 Nov; 14(6):395-8. PubMed ID: 19008746
[TBL] [Abstract][Full Text] [Related]
13. [Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage].
Raabe A; Beck J; Berkefeld J; Deinsberger W; Meixensberger J; Schmiedek P; Seifert V; Steinmetz H; Unterberg A; Vajkoczy P; Werner C;
Zentralbl Neurochir; 2005 May; 66(2):79-91. PubMed ID: 15846536
[TBL] [Abstract][Full Text] [Related]
14. Medically induced hypertension, hypervolaemia and haemodilution for the treatment and prophylaxis of vasospasm following aneurysmal subarachnoid haemorrhage: systematic review.
Loan JJM; Wiggins AN; Brennan PM
Br J Neurosurg; 2018 Apr; 32(2):157-164. PubMed ID: 29338431
[TBL] [Abstract][Full Text] [Related]
15. Routine management of volume status after aneurysmal subarachnoid hemorrhage.
Wolf S;
Neurocrit Care; 2011 Sep; 15(2):275-80. PubMed ID: 21748500
[TBL] [Abstract][Full Text] [Related]
16. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
17. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.
Awad IA; Carter LP; Spetzler RF; Medina M; Williams FC
Stroke; 1987; 18(2):365-72. PubMed ID: 3564092
[TBL] [Abstract][Full Text] [Related]
18. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
Liu-Deryke X; Rhoney DH
Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
[TBL] [Abstract][Full Text] [Related]
19. Triple H therapy after aneurysmal subarachnoid hemorrhage. A review.
Romner B; Reinstrup P
Acta Neurochir Suppl; 2001; 77():237-41. PubMed ID: 11563296
[No Abstract] [Full Text] [Related]
20. Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new systemic hemodynamic parameters.
Krayenbühl N; Hegner T; Yonekawa Y; Keller E
Acta Neurochir Suppl; 2001; 77():247-50. PubMed ID: 11563298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
